Atlas Trials

Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

RecordFirmDate
Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) (NCT03340766)Amgen2018-03-16

Track Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) automatically

Every clearance here is in the API, with alerts when new ones post.